JRC Publications Repository

JRC Publications Repository > Joint Research Centre > Institute for Reference Materials and Measurements >

Please use this identifier to cite or link to this item: http://publications.jrc.ec.europa.eu/repository/handle/111111111/12401

Title: Class III ß-Tubulin Isotope Predicts Response in Advanced Breast Cancer Patients Randomly Treated Either with Single-agent Doxorubicin or Docetaxel
Authors: GALMARINI Carlos M.
TREILLEUX Isabelle
CARDOSO Fatima
BERNARD-MARTY Chantal
DURBECQ Virginie
GANCBERG David
BISSERY Marie-Christine
PAESMANS Marianne
LARSIMONT Denis
PICCART Martine J.
DI LEO Angelo
DUMONTET Charles
Citation: CLINICAL CANCER RESEARCH vol. 14 no. 14 p. 4511-4516
Publisher: AMER ASSOC CANCER RESEARCH
Publication Year: 2008
JRC Publication N°: JRC47227
ISSN: 1078-0432
URI: http://publications.jrc.ec.europa.eu/repository/handle/111111111/12401
DOI: 10.1158/1078-0432.CCR-07-474
Type: Articles in Journals
Appears in Collections:Institute for Reference Materials and Measurements

Files in This Item:

There are no files associated with this item.

Items in repository are protected by copyright, with all rights reserved, unless otherwise indicated.

 

The mission of the JRC is to provide customer-driven scientific and technical support for the conception, development, implementation and monitoring of EU policies. As a service of the European Commission, the JRC functions as a reference centre of science and technology for the Union. Close to the policy-making process, it serves the common interest of the Member States, while being independent of special interests, whether private or national.
Powered by DSpace
Top